A Clinical Trial of Levocarnitine to Treat Autism Spectrum Disorders
Completed
- Conditions
- Autism Spectrum Disorder (ASD)Mental and Behavioural DisordersPervasive developmental disorders
- Registration Number
- ISRCTN54273114
- Lead Sponsor
- Autism Research Institute (USA)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1. Subjects diagnosed with an ASD
2. Aged from 3 to 10 yrs-old (males and females)
3. Study subject bodyweights between 13.2 Kg to 40.4 Kg
Exclusion Criteria
1. No study subject previously received carnitine-based therapy or previous methionine or lysine supplementation
2. No study subject had any change in therapy or treatment (including medications) within 1 month prior to the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method